港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

映恩生物-B

307.600

-12.400-3.87%

成交量：22.02萬

成交額：6,840.67萬

市值：277.57億

市盈率：-6.74

高：324.800

開：321.000

低：307.000

收：320.000

52周最高：563.500

52周最低：165.500

股本：9,023.80萬

香港流通股本：9,023.80萬

量比：0.77

換手率：0.24%

股息：- -

股息率：- -

每股收益(LYR):-45.648

淨資產收益率：-1282.14%

總資產收益率：-9.61%

市淨率：9.97

市盈率(LYR):-6.74

市銷率: 13.07

資料載入中...

總覽公司新聞資訊公告

映恩生物-B02月09日主力淨流入167.6萬元散户資金拋售

醫藥行業跟蹤報告：信達生物與禮來合作再度升級打造全球創新生態體系

映恩生物1月股份變動及期權行使情況

映恩生物（09606）更新2026年1月股份變動月報表，股本小幅增加

映恩生物-B02月05日遭主力拋售222.8萬元

每日沽空追蹤 | 映恩生物-B 02月04日沽空量成交2.95萬股，沽空比例為4.08%

《大行》大摩列出港股焦點股名單(表)

阿斯达克财经

映恩生物-B跌4.21% 股價跌破300港元大關

醫藥行業跟蹤報告：MNC重金加碼中國創新藥，中國IO2.0雙抗出海邁出關鍵一步

每日沽空追蹤 | 映恩生物-B 02月02日沽空量成交2.92萬股，沽空比例為5.23%

華福精選｜本周重點推薦

醫藥生物行業跟蹤周報：降息等多因素支持科研上游持續復甦重點推薦皓元醫藥、奧浦邁等

醫藥生物行業靶向PAM通路潛在百億美元市場：和黃醫藥及CELCUITY

每日沽空追蹤 | 映恩生物-B 01月30日沽空量成交1.76萬股，沽空比例為2.88%

映恩生物-B盤中異動股價大漲5.22%

映恩生物-B01月28日主力淨流入1097.0萬元散户資金拋售

每日沽空追蹤 | 映恩生物-B 01月27日沽空量成交4.49萬股，沽空比例為7.9%

BioNTech啓動B7-H3 ADC首個III期臨床試驗料2031年1月取得結果

阿斯达克财经

港股異動 | 映恩生物-B(09606)升逾6% 公司2026年臨床數據有望密集讀出

華福證券：醫藥生物業新技術全面突破戰略看多中國創新出海

智通财经网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/09606/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":307.6,"timestamp":1776395008263,"preClose":320,"halted":0,"volume":220188,"delay":0,"changeRate":-0.03874999999999993,"floatShares":90238000,"shares":90238000,"eps":-45.648047535542055,"marketStatus":"交易中","change":-12.4,"latestTime":"04-17 11:03:38","open":321,"high":324.8,"low":307,"amount":68406740,"amplitude":0.055625,"askPrice":307.6,"askSize":1900,"bidPrice":307,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-36.55513997620092,"tradingStatus":2,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1776398400000},"marketStatusCode":2,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":320,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.772794,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90238000,"roa":"-9.61%","roe":"-1282.14%","lyrEps":-45.648048,"volumeRatio":0.772794,"shares":90238000,"dividePrice":0,"high":324.8,"amplitude":0.055625,"preClose":320,"low":307,"week52Low":165.5,"pbRate":"9.97","psRate":"13.07","week52High":563.5,"institutionHeld":0,"latestPrice":307.6,"committee":-0.9,"eps":-45.648047535542055,"divideRate":0,"volume":220188,"delay":0,"ttmEps":-36.55513997620092,"open":321,"prevYearClose":298.2,"prevWeekClose":303,"prevMonthClose":295,"prevQuarterClose":295,"fiveDayClose":303,"twentyDayClose":296,"sixtyDayClose":362.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1761235200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-04-16","current":-8.414685,"percent":0.54065,"low":-29.984477,"twenty":-18.917766,"median":-9.824687,"eighty":-8.838295,"high":-7.368305,"avg":-13.535991,"sd":6.209129,"marketCap":28844068480},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-16","current":-9.691452,"twenty":-18.917766,"median":-9.824687,"eighty":-8.838295,"marketCap":28844068480}],"updateTime":1776395018901},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610863208","title":"映恩生物-B02月09日主力淨流入167.6萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610863208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610863208?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 16:15","pubTimestamp":1770624943,"startTime":"0","endTime":"0","summary":"02月09日, 映恩生物-B股价涨3.81%，报收327.00元，成交金额1.7亿元，换手率0.56%，振幅6.92%，量比0.90。映恩生物-B今日主力资金净流入167.6万元，上一交易日主力净流出161.4万元。该股近5个交易日上涨2.96%，主力资金累计净流出1767.6万元；近20日主力资金累计净流入5097.5万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162100a48e473f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162100a48e473f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610320536","title":"醫藥行業跟蹤報告：信達生物與禮來合作再度升級 打造全球創新生態體系","url":"https://stock-news.laohu8.com/highlight/detail?id=2610320536","media":"爱建证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610320536?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 00:00","pubTimestamp":1770566400,"startTime":"0","endTime":"0","summary":"信达生物与礼来合作再度升级，打造全球创新生态体系。2 月8 日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。信达生物将获得3.5 亿美元首付款和最高约85 亿美元的研发、监管及商业化里程碑付款，以及各产品在大中华区以外的净销售额获得梯度的销售分成。本次合作突破了传统的授权模式，双方优势互补、深度绑定，打造了无缝衔接的端到端创新生态体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209170152a6e56af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209170152a6e56af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","HK0000252152.HKD","LU2328871848.SGD","BK1583","LU2097828474.EUR","LU0502904849.HKD","BK1589","LU2097828714.EUR","LU2097828805.USD","BK1161","LU1969619763.USD","LU2488822045.USD","HK0000500386.USD","LU2242644610.SGD","HK0000252160.HKD","LU2097828557.USD","HK0000165453.HKD","09606","LU2097828631.EUR","LU2543165471.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609589024","title":"映恩生物1月股份變動及期權行使情況","url":"https://stock-news.laohu8.com/highlight/detail?id=2609589024","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609589024?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 03:52","pubTimestamp":1770321134,"startTime":"0","endTime":"0","summary":"金吾财讯|映恩生物于2026年2月5日提交了截至2026年1月31日的股份变动月报表。在法定/注册股本方面，公司普通股的上月底结存和本月底结存的法定/注册股份数目、面值及总额均未发生变动。公司已确认截至1月底符合适用的公众持股量要求。本月因行使期权所得资金总额为2,254,833.7港元。此外，公司在回购股份、承诺发行权证、可换股票据等方面均无相关情况。映恩生物在各项证券相关事务的操作中均遵循了相关规定和流程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206042647a481717e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206042647a481717e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","09606","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123055979","title":"映恩生物（09606）更新2026年1月股份變動月報表，股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1123055979","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123055979?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 17:39","pubTimestamp":1770284340,"startTime":"0","endTime":"0","summary":"映恩生物于2026年2月5日发布截至2026年1月31日的股份变动月报表。报告显示，公司法定股本维持在200,000,000股，面值每股0.0001美元，注册股本总额20,000美元，期间无变化。公司并未进行任何股份回购、注销或库存股份变动。截至2026年1月31日，公司已发行股本总数上升至90,137,714股。映恩生物确认继续符合香港联交所规定的最低公众持股量要求。根据公告披露，此报告由联席公司秘书袁佳丽签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609037822","title":"映恩生物-B02月05日遭主力拋售222.8萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609037822","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609037822?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 16:15","pubTimestamp":1770279324,"startTime":"0","endTime":"0","summary":"02月05日，映恩生物-B股价收平报318.40元，成交金额1.2亿元，换手率0.41%，振幅4.52%，量比0.63。映恩生物-B今日主力资金净流出222.8万元，连续3日净流出，上一交易日主力净流出1182.0万元。该股近5个交易日下跌4.86%，主力资金累计净流出890.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入5930.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161640a6d63fa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161640a6d63fa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","09606","BK1161","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609312324","title":"每日沽空追蹤 | 映恩生物-B 02月04日沽空量成交2.95萬股，沽空比例為4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609312324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609312324?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 16:30","pubTimestamp":1770193841,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月04日，涨1.66%，卖空量成交2.95万股，较上一交易日减少73.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163834a6d206a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163834a6d206a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608533973","title":"《大行》大摩列出港股焦點股名單(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608533973","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608533973?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 15:16","pubTimestamp":1770189360,"startTime":"0","endTime":"0","summary":"摩根士丹利发表中国市场策略报告，列出港股及中资股焦点股名单，剔出长江电力，同时纳入中铝：股份│股价较目标价潜在升幅阿里巴巴│3.3%中铝│-1.9%宁德时代│43.3%映恩生物-B│46.4%乐鑫科技│29.1%港交所│14.5%香港电讯—SS│11.3%国电南瑞│5.5%中国平安│21.6%汇川技术│25.2%中材科技│15.7%春秋航空│11.5%舜宇光学│43.3%腾讯│18.3%紫金矿业│28%(港股报价延迟最少十五分钟。)相关内容《大行》汇丰研究对内险股投资评级及目标价(表)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180509171355653_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180509171355653_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1501053/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1501053/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["300124","600406","HKXCY","LU0348784397.USD","LU1282651121.HKD","06823","LU0261950470.USD","80388","LU0264606111.USD","09606","02318","601021","82318","HK0000288784.HKD","LU0124384867.USD","03145","IE00B031HY20.USD","HTCD.SI","LU0823040885.USD","LU0823414478.USD","HK0000352291.HKD","LU1868838027.USD","00388","601600","LU2106854487.HKD","HPAD.SI","601318","SG9999002562.SGD","002080","EVS.SI","00700","300750","LU0488056044.USD","LU2125910500.SGD","02382","BK0224","TCHmain","LU2294711713.HKD","PNGAY","SG9999003461.SGD","LU0823437842.USD","LU2399975544.HKD","IE0005HP3H50.USD","LU0348827113.USD","PAImain","688018","LU1439102457.SGD","600900","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2609131232","title":"映恩生物-B跌4.21% 股價跌破300港元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2609131232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609131232?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 10:56","pubTimestamp":1770173779,"startTime":"0","endTime":"0","summary":"2026年02月04日早盘10时56分，映恩生物-B股票出现波动，股价大幅跳水4.21%。截至发稿，该股报300.000港元/股，成交量21.83万股，换手率0.24%，振幅4.73%。映恩生物-B股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，轩竹生物-B、北海康成-B、歌礼制药-B涨幅较大，振幅较大的相关个股有帝王国际投资、圣诺医药-B、奥星生命科技，振幅分别为18.02%、11.93%、11.90%。映恩生物-B公司简介：映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020410561997a4c489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020410561997a4c489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608186448","title":"醫藥行業跟蹤報告：MNC重金加碼中國創新藥，中國IO2.0雙抗出海邁出關鍵一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2608186448","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608186448?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 18:07","pubTimestamp":1770026824,"startTime":"0","endTime":"0","summary":"投资要点：医药板块行情复盘：本周市场以震荡调整为主，SW医药生物指数下跌3.31%，在申万一级行业指数中排名22/31，跑输沪深300指数；各细分板块中，血液制品、疫苗表现相对较好，主要与尼帕病毒概念相关，部分CXO个股由于业绩催化表现较为突出，线下药店和医院表现较弱。依沃西海外上市申请获美国FDA受理，全球市场拓展迈出关键一步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202180714a6c9e2ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202180714a6c9e2ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","HK0000165453.HKD","09606","BK1161","06978","01530","BK1593","09926","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608484224","title":"每日沽空追蹤 | 映恩生物-B 02月02日沽空量成交2.92萬股，沽空比例為5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608484224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608484224?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 16:30","pubTimestamp":1770021041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月02日，跌3.7%，卖空量成交2.92万股，较上一交易日减少62.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163913a47290f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163913a47290f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD","BK1161","09606","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608034620","title":"華福精選｜本周重點推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2608034620","media":"华福研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608034620?lang=zh_tw&edition=fundamental","pubTime":"2026-02-01 08:50","pubTimestamp":1769907013,"startTime":"0","endTime":"0","summary":"六、CPI弹性强于PPI。经济恢复不及预期。03地缘扰动、“抛售美债”与金银核心观点：行业热点：特斯拉可能在2027年年底前向公众销售人形机器人，马斯克欲部署太空光伏。1月下旬正处于年报业绩预披露的密集期，当前可对有业绩基本面支撑的方向保持关注。此外，在市场仍对弹性保有追求的情况下，可对小盘风格、“马斯克链”保持关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201095855a6c506ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201095855a6c506ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1170","01877","09995","02865","02157","01093","01999","02696","09606","06613","00013","02616","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608888327","title":"醫藥生物行業跟蹤周報：降息等多因素支持科研上游持續復甦 重點推薦皓元醫藥、奧浦邁等","url":"https://stock-news.laohu8.com/highlight/detail?id=2608888327","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608888327?lang=zh_tw&edition=fundamental","pubTime":"2026-02-01 00:00","pubTimestamp":1769875200,"startTime":"0","endTime":"0","summary":"建议关注皓元医药、百奥赛图、百普赛斯、奥浦迈、药康生物、纳微科技和阿拉丁等。从小核酸角度，建议关注前沿生物、福元医药、悦康药业等。从GLP1 角度，建议关注联邦制药、博瑞医药、众生药业、信达生物等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201204647a46f7473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201204647a46f7473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1574","06978","BK1161","09606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608888201","title":"醫藥生物行業靶向PAM通路潛在百億美元市場：和黃醫藥及CELCUITY","url":"https://stock-news.laohu8.com/highlight/detail?id=2608888201","media":"华福证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608888201?lang=zh_tw&edition=fundamental","pubTime":"2026-02-01 00:00","pubTimestamp":1769875200,"startTime":"0","endTime":"0","summary":"靶向PAM 通路市场空间大，关注Celcuity、和黄医药：PAM 通路突变发生在38%肿瘤患者中，其中覆盖乳腺癌和前列腺癌两大癌种。Celcuity 开发的Gedatolisib 是唯一在PIK3CA MT 和WT 中均显示出相似活性的PAM 抑制剂。计划于2026 年第一季度末或第二季度公布VIKTORIA-1 研究中PIK3CA 突变队列的顶线数据。除了HR+ HER2-型晚期乳腺癌，HER2 阳性乳腺癌患者也存在约38%的PAM 通路改变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201184134a6c626b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201184134a6c626b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","09606","BK1161","HK0000252160.HKD","BK1587","BK1191","BK1588","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607648017","title":"每日沽空追蹤 | 映恩生物-B 01月30日沽空量成交1.76萬股，沽空比例為2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607648017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607648017?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 16:30","pubTimestamp":1769761843,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月30日，跌2.19%，卖空量成交1.76万股，较上一交易日减少28.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164213a6bf4fbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164213a6bf4fbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607017674","title":"映恩生物-B盤中異動 股價大漲5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607017674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607017674?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 09:31","pubTimestamp":1769736699,"startTime":"0","endTime":"0","summary":"2026年01月30日早盘09时31分，映恩生物-B股票出现波动，股价急速上涨5.22%。截至发稿，该股报354.800港元/股，成交量9.3733万股，换手率0.10%，振幅6.23%。映恩生物-B股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，同源康医药-B、百奥赛图-B、诺诚健华涨幅较大，振幅较大的相关个股有百奥赛图-B、诺诚健华、维亚生物，振幅分别为11.00%、7.06%、6.67%。映恩生物-B公司简介：映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013009313997a40e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013009313997a40e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606714347","title":"映恩生物-B01月28日主力淨流入1097.0萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606714347?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 16:15","pubTimestamp":1769588152,"startTime":"0","endTime":"0","summary":"01月28日, 映恩生物-B股价涨3.07%，报收349.00元，成交金额2.2亿元，换手率0.70%，振幅6.08%，量比1.07。映恩生物-B今日主力资金净流入1097.0万元，上一交易日主力净流出373.6万元。该股近5个交易日下跌0.06%，主力资金累计净流入885.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.5亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162313a45f74c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162313a45f74c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606754215","title":"每日沽空追蹤 | 映恩生物-B 01月27日沽空量成交4.49萬股，沽空比例為7.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606754215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606754215?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 16:30","pubTimestamp":1769502644,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月27日，涨5.42%，卖空量成交4.49万股，较上一交易日增加81.78%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164256a6b23a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164256a6b23a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252160.HKD","09606","LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606372201","title":"BioNTech啓動B7-H3 ADC首個III期臨床試驗  料2031年1月取得結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2606372201","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606372201?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 16:23","pubTimestamp":1769502180,"startTime":"0","endTime":"0","summary":"美国ClinicalTrials.gov网站显示，BioNTech启动DB-1311/BNT324的首个III期临床试验，预计招募736人，将于2031年1月取得结果。BNT324是映恩生物(09606.HK) 开发的一款B7-H3 ADC，于2023年4月被授权至BioNTech，该公司拥有该药物在中国以外的开发、生产和商业化权益。(sl/j)(港股报价延迟最少十五分钟。沽空资料截至 2026-01-27 12:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260127163140020_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260127163140020_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1499036/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1499036/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000500386.USD","LU2543165471.USD","09606","HK0000252160.HKD","BK1161","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606840208","title":"港股異動 | 映恩生物-B(09606)升逾6% 公司2026年臨床數據有望密集讀出","url":"https://stock-news.laohu8.com/highlight/detail?id=2606840208","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606840208?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 14:24","pubTimestamp":1769495043,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B涨超6%，截至发稿，涨6.04%，报340.6港元，成交额1.54亿港元。该药物是第5款进入III期阶段的B7-H3 ADC。BNT324是映恩生物开发的一款B7-H3 ADC，于2023年4月被授权至BioNTech，该公司拥有该药物在中国以外的开发、生产和商业化权益。国联民生证券指出，2026年ADC+IO与核心单药临床数据集中读出。该行认为，映恩生物引领ADC迭代浪潮，2026年有望迎来商业化。映恩生物持续开发下一代新型ADC，包括双抗ADC，全新机制载荷ADC和自免ADC。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606272282","title":"華福證券：醫藥生物業新技術全面突破 戰略看多中國創新出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272282","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606272282?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 11:01","pubTimestamp":1769482871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华福证券发布研报称，2025年中国创新药全球竞争力凸显，出海交易创新高，多家企业扭亏为盈。战略看多中国创新出海。华福证券主要观点如下：国内复盘：全球竞争力凸显，企业扭亏为盈+管线出海价值新高度2025创新药指数大涨，Biopharma和Biotech持仓比例显著提升，核心驱动因素是中国创新药全球竞争力凸显。创新药市场份额快速提升，肿瘤与免疫领域创新药份额超32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","02162","09606","01530","09887","06938","BK1583","02157","06978","BK1161","02096","BK1593","BK1574","01276","06955","09926","01801","HK0000165453.HKD","02615","01672","01093"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}